semaglutide eye issues A nurse lost her eyesight while on GLP-1 drugs. She said she did not know of the potential risk, which is listed on the packaging in Europe but not in the U.S Ophthalmologic Manifestations from Semaglutide (Ozempic/Wegovy)

In contrast, the risk for right heart failure among those using GLP-1 receptor agonists did not significantly differ from the risk among those not using GLP-1 receptor agonists

10.3389/fmed.2020.00237 118 RuanZ.LiuJ.ZhaoJ

Cerebellar tDCS and Motor Learning (D

Similarly, Luteolin and Alpha Lipoic Acid (ALA) are being investigated for their ability to support the nervous system and manage oxidative stress

The results suggested that at week 12 after treatment discontinuation, there was no significant difference in weight regain between significant and not significant weight loss subgroup ( P = 0.99) (Additional file 2: Fig